Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Prostate Cancer Prostatic Dis. 2020 Jul 10;24(1):140–149. doi: 10.1038/s41391-020-0254-y

Fig. 4. Quantification of CD4+ and CD8+ T cells in patients peripheral blood samples.

Fig. 4

a Quantification of CD4+ and CD8+ T cells in blood samples of early responder patient PT-01 at different stages: B0 (Baseline blood), B1 (Blood collected after two cycles of nivolumab, and prior to HDR#1) and B2 (Specimen collected after 4 cycles of nivolumab and four weeks after HDR#1, but prior to HDR#2). b Quantification of CD4+ and CD8+ T cells in blood samples of late responder patient PT-03.